| Barry Gardner, MD | |
|
1400 N 500 E, Logan, UT 84341-2455 | |
| (435) 716-1000 | |
| Not Available |
| Full Name | Barry Gardner |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 1400 N 500 E, Logan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922049923 | NPI | - | NPPES |
| 807469200 | Medicaid | ID | |
| P00393212 | Other | RAILROAD MEDICARE | |
| D1618 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 319532 (Utah) | Secondary |
| 208D00000X | General Practice | 319532-1205 (Utah) | Primary |
| Entity Name | Emergency Physicians Integrated Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598199 PECOS PAC ID: 4284548116 Enrollment ID: O20031115000013 |
News Archive
CarePoint Partners, one of the largest, fastest growing independent home infusion therapy companies in the United States, launched a food drive today throughout its twenty-one locations in eight states to help the less fortunate in the communities where it operates.
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The health care ads being run by Americans for Prosperity -; one of the many frantically waving arms of the Koch brothers -; are a gift to fact checkers everywhere. Because they deliberately twist the truth to persuade people to "stop supporting Obamacare," they have become a machine for producing "Pinocchios," the mendacity rating system used by Glenn Kessler at The Washington Post (David Firestone, 4/24).
A new LSU Pennington Biomedical Research Center study reveals that a novel biomarker might give us new answers necessary to creating a diagnostic tool for hypoglycemia-associated autonomic failure.
› Verified 6 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003090879 PECOS PAC ID: 9739260019 Enrollment ID: O20091207000033 |
News Archive
CarePoint Partners, one of the largest, fastest growing independent home infusion therapy companies in the United States, launched a food drive today throughout its twenty-one locations in eight states to help the less fortunate in the communities where it operates.
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The health care ads being run by Americans for Prosperity -; one of the many frantically waving arms of the Koch brothers -; are a gift to fact checkers everywhere. Because they deliberately twist the truth to persuade people to "stop supporting Obamacare," they have become a machine for producing "Pinocchios," the mendacity rating system used by Glenn Kessler at The Washington Post (David Firestone, 4/24).
A new LSU Pennington Biomedical Research Center study reveals that a novel biomarker might give us new answers necessary to creating a diagnostic tool for hypoglycemia-associated autonomic failure.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barry Gardner, MD Po Box 25535, Salt Lake City, UT 84125-0535 Ph: (866) 898-7136 | Barry Gardner, MD 1400 N 500 E, Logan, UT 84341-2455 Ph: (435) 716-1000 |
News Archive
CarePoint Partners, one of the largest, fastest growing independent home infusion therapy companies in the United States, launched a food drive today throughout its twenty-one locations in eight states to help the less fortunate in the communities where it operates.
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The health care ads being run by Americans for Prosperity -; one of the many frantically waving arms of the Koch brothers -; are a gift to fact checkers everywhere. Because they deliberately twist the truth to persuade people to "stop supporting Obamacare," they have become a machine for producing "Pinocchios," the mendacity rating system used by Glenn Kessler at The Washington Post (David Firestone, 4/24).
A new LSU Pennington Biomedical Research Center study reveals that a novel biomarker might give us new answers necessary to creating a diagnostic tool for hypoglycemia-associated autonomic failure.
› Verified 6 days ago
Dr. Ryan H Larsen, MD General Practice Medicare: Medicare Enrolled Practice Location: 258 S Main St Ste 210, Logan, UT 84321 Phone: 435-383-6120 Fax: 435-557-8003 |